You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 20, 2025

Drug Price Trends for NDC 51862-0892


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 51862-0892

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 51862-0892

Understanding the NDC Code

The National Drug Code (NDC) 51862-0892 is a unique identifier for a specific drug product. This code is divided into three segments: the labeler code, the product code, and the package code. For NDC 51862-0892, the labeler code "51862" identifies Mayne Pharma Inc., the product code identifies the specific drug formulation, and the package code specifies the package size and type[4].

Drug Identification

The NDC 51862-0892 corresponds to the drug "Necon," which is a contraceptive medication manufactured by Mayne Pharma Inc.[1].

Market Analysis

Current Market Trends

The pharmaceutical market is experiencing significant changes, including rising drug prices and the introduction of new, high-cost therapies. According to Vizient's summer 2024 Pharmacy Market Outlook, the overall drug price inflation rate for 2025 is projected to be 3.81%[3][5].

Specific Drug Trends

For Necon (NDC 51862-0892), market trends would typically be influenced by factors such as demand, competition from other contraceptive medications, and regulatory changes. However, specific price trends for this NDC are not publicly available in the same detail as more broadly tracked medications.

Price Projections

General Pharmaceutical Price Inflation

Given the projected overall drug price inflation rate of 3.81% for 2025, it is reasonable to expect that prices for Necon and similar medications could increase accordingly. This inflation rate is driven by various factors, including the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[3][5].

Historical Pricing Context

While specific historical pricing data for NDC 51862-0892 is not provided, it is important to note that drug prices can fluctuate based on market conditions, manufacturing costs, and regulatory changes. For example, other medications have shown price variations over time due to these factors[2].

Factors Influencing Price

Regulatory Environment

Changes in regulatory requirements or compliance issues can impact the pricing and availability of drugs. For instance, if a manufacturer fails to comply with FDA listing obligations, the product may not be included in the NDC Directory, which could affect its market presence and pricing[4].

Market Demand and Competition

Demand for contraceptive medications like Necon can influence pricing. High demand coupled with limited competition could lead to higher prices, while increased competition might result in more stable or lower prices.

Manufacturing and Distribution Costs

Costs associated with manufacturing, distribution, and packaging can also affect the final price of the drug. Any changes in these costs, such as increases in raw material prices or distribution expenses, could be reflected in the drug's market price.

Impact on Healthcare Providers and Consumers

Budgetary Considerations

Healthcare providers and consumers need to be aware of potential price increases to manage budgets effectively. A projected inflation rate of 3.81% for pharmaceuticals means that providers and consumers should prepare for higher costs in the coming year[3].

Access to Medication

Price increases can affect access to medications, particularly for those with limited financial resources. It is crucial for healthcare systems to develop sustainable financial models to ensure that essential medications remain accessible.

Key Takeaways

  • NDC Code: The NDC 51862-0892 identifies Necon, a contraceptive medication by Mayne Pharma Inc.
  • Market Trends: The pharmaceutical market is experiencing a projected 3.81% price inflation rate for 2025.
  • Price Projections: Prices for Necon are likely to increase in line with overall pharmaceutical price inflation.
  • Regulatory and Market Factors: Pricing is influenced by regulatory compliance, market demand, competition, and manufacturing costs.
  • Impact on Healthcare: Price increases can affect budgetary planning and access to medications.

FAQs

What is the NDC code 51862-0892?

The NDC code 51862-0892 identifies the drug Necon, a contraceptive medication manufactured by Mayne Pharma Inc.

What is the projected drug price inflation rate for 2025?

The projected overall drug price inflation rate for 2025 is 3.81% according to Vizient's summer 2024 Pharmacy Market Outlook.

How do regulatory changes affect drug pricing?

Regulatory changes, such as compliance issues or changes in listing obligations, can impact the pricing and availability of drugs by affecting their market presence.

What factors influence the price of Necon?

The price of Necon is influenced by market demand, competition, manufacturing and distribution costs, and regulatory changes.

How can healthcare providers prepare for price increases?

Healthcare providers should monitor market trends, adjust budgetary plans accordingly, and develop sustainable financial models to manage the impact of price increases on their operations.

Sources

  1. Mayne Pharma - List of Drugs - NDC Labeler/Manufacturer. FindACode.
  2. Latest drug prices and trends for NDC 70069-0820. DrugPatentWatch.
  3. Vizient projects drug price inflation at 3.81%. Vizient Inc.
  4. National Drug Code Database Background Information - FDA. FDA.
  5. Pharmacy Market Outlook Summer 2024 - Vizient Inc.. Vizient Inc.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.